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ypass Surgery After
on–ST-Segment Elevation
yocardial Infarction
etter Early Than Late?*
effrey L. Anderson, MD, John R. Doty, MD
urray, Utah
he Clinical Question
n addressing the question of timing of coronary artery
ypass graft (CABG) surgery after ST-segment elevation
yocardial infarction (STEMI), the 2004 American Col-
ege of Cardiology/American Heart Association (ACC/
HA) guidelines for the management of patients with
TEMI (1) gives the following Class IIa recommendation:
In patients who have had a STEMI, CABG mortality is
levated for the first 3 to 7 days after infarction, and the
enefit of revascularization must be balanced against this
ncreased risk. Patients who have been stabilized (no on-
oing ischemia, hemodynamic compromise, or life-
hreatening arrhythmia) after STEMI and who have in-
urred a significant fall in LV function should have their
urgery delayed to allow myocardial recovery to occur. If
ritical anatomy exists, revascularization should be under-
aken during the index hospitalization. (Level of Evidence:
)”. The text then continues: “the Writing Committee
elieves that if stable STEMI patients with preserved LV
unction require surgical revascularization, then CABG can
e undertaken within several days of the infarction without
n increased risk.”
See page 419
No other specific recommendations on timing of CABG
fter STEMI or non–ST-segment elevation myocardial
nfarction (NSTEMI) are made in the 2007 and recently
ublished 2009 focused guideline updates for management
f STEMI (2,3), in the ACC/AHA 2007 UA/NSTEMI
uidelines (4), or in the ACC/AHA 2004 guidelines update
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.C
From the Cardiovascular Department, Intermountain Medical Center, University
f Utah School of Medicine, Murray, Utah.or coronary artery bypass surgery (5). This last reference
oes state that the “risk of CABG in patients with unstable
ngina, post-infarction angina, early after non-STEMI and
uring acute MI is increased several fold relative to patients
ith stable angina, although the risk is not necessarily
igher than that of medical therapy in these patients” (5).
he CABG writing committees in 2004 and the earlier
999 version (6) provide multiple references reporting an
ncreased risk of mortality after CABG across the acute
oronary syndromes spectrum, and they generalize that
perative mortality decreases as time to operation increases.
owever, previous studies frequently have lumped together
STEMI with STEMI and urgent with nonurgent cases,
nd the few teasing out NSTEMI have provided conflicting
esults on the safety of early CABG (7–11).
Given the confusion about the optimal timing of CABG
n stable NSTEMI patients, advances in medical and
urgical therapy, and the ongoing challenge of optimiz-
ng both patient outcomes and resource utilization, the
urrent paper by Parikh et al. (12) in this issue of JACC:
ardiovascular Interventions is of considerable contemporary
nterest.
tudy Summary
arikh et al. (12) use merged major national databases that
nrolled NSTEMI patients between January 1, 2002, and
une 30, 2008, to address key questions about temporal
rends in CABG use, timing, and clinical outcomes. The
rst 2 questions were addressed by a merger of the earlier
RUSADE (Can Rapid Risk Stratification of Unstable
ngina Patients Suppress Adverse Outcomes With Early
mplementation of the ACC/AHA Guidelines) registry and
he ongoing ACTION (Acute Coronary Treatment and
ntervention Outcomes Network) registry–GWTG (Get
ith The Guidelines) database, which yielded 109,169
ligible patients from 475 centers. The third question was
ddressed by the ACTION registry–GWTG database,
hich yielded 2,647 CABG operations with timing infor-
ation among 21,470 qualifying patients in 202 centers.
arly CABG was defined as occurring 48 h and delayed
ABG as 48 h after hospital arrival (7,9). The primary
utcome was a composite of death, MI, cardiogenic shock,
r heart failure. Increased bleeding after CABG was defined
s transfusion of 2 red blood cell units. Patient risk profile
as characterized by the GRACE (Global Registry of
cute Coronary Events) score (13). Generalized estimating
quations methods were used to explore the relationship
etween CABG timing and in-hospital outcomes.
In-hospital CABG rates after NSTEMI (11% to 13%)
nd the proportion undergoing early (30%) versus later
ABG (70%) did not change significantly between 2002
nd 2008. Early CABG occurred at medians of 29 (early
ABG) and 102 h (delayed CABG), and angiography, at 9
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429nd 28 h after admission, respectively. Three-vessel disease
in 73%) and median peak troponin were similar in the 2
ubgroups. Late CABG patients were older, more often
omen, had a higher risk profile except for cardiogenic
hock, and more frequently received in-hospital clopidogrel
nd low molecular weight heparin.
Despite the differences in baseline characteristics, sub-
roup outcomes were similar. The composite adverse clin-
cal end point occurred in 12.6% of early and 12.4% of
elayed subgroup patients, and each component of the end
oint was similar, including death (3.6% vs. 3.8%). This
argely equivalent profile persisted after multivariable adjust-
ent. Delayed surgery patients had a slightly greater chance
f receiving 2 red cell units (55% vs. 48%), and their
ospital stays were longer (11 vs. 7 days).
linical Interpretation and Implications
arikh et al. (12) are to be congratulated for investigating an
mportant, poorly defined area of decision making in coro-
ary care. To do this, they took advantage of uniquely large,
ich, and overlapping contemporary U.S. databases. A first
bservation, that CABG surgery rates after NSTEMI have
een maintained over the past 6 years, came as a surprise,
iven the decade-plus trend of increasing percutaneous
oronary intervention and decreasing CABG rates. The
ncreasing use of an invasive strategy and persistently high
ates of 3-vessel disease (73%) were offered as an explana-
ion. The further finding of a 2:1 preference for delayed
urgery may reflect an extension of STEMI recommenda-
ions into NSTEMI decision making. These observations
rgue for new evidence to guide decision making in
STEMI.
Also, perhaps surprisingly, clinical outcomes after early
nd later CABG were similar. However, the early and
elayed groups differed in many respects, raising concern
bout the impact of selection bias. To address this, the
nvestigators applied sophisticated statistical modeling (i.e., the
eneralized estimating equations method), enabling adjust-
ent for correlations within centers and correlations and
ariations among centers. Multivariable analyses were adjusted
or 21 patient-specific baseline variables. Despite these exhaus-
ive adjustments, outcomes remained equivalent.
Exploring upstream “process” factors that might influence
iming, the investigators found a 19-h median delay to
oronary angiography and increased pre-operative use of
lopidogrel (14) and low molecular weight heparin (15) in
he delayed CABG subgroup, which current guidelines
ecommend withholding for 5 to 7 days and 12 to 24 h,
espectively, before nonurgent CABG (4).
The study has several limitations, including the possibility
f residual confounding, which can be argued both ways:
ccounting for survivor bias (favoring the delayed group)
ould reinforce the safety of early surgery, whereas incom-lete adjustment for higher risk characteristics of the de-
ayed group would inappropriately favor early CABG. The
hort (in-hospital) follow-up is a further limitation, and
he intermediate patient risk leaves open the question of the
afety of early, nonurgent CABG in high-risk patients. The
ut point of 48 h between early and delayed surgery is
rbitrary and another cut point might be optimal. Time
rom onset of MI symptoms would be of interest in addition
o time of admission. Finally, observational studies are
imited to discovering associations rather than establishing
ause-effect relationships.
Despite these limitations, this study sheds much new
ight on the question of timing of CABG after NSTEMI,
hich importantly differs from STEMI in pathology, prog-
osis, and initial management. Limitations of earlier studies
ave led to uncertainty about the relative benefits and risks
f early versus delayed surgery. Into this confusing knowl-
dge gap, this study provides the most objective, compelling
bservational data yet. The investigators argue that delaying
urgery routinely in all patients after uncomplicated NSTEMI
s not warranted and may increase resource utilization
ithout improving outcomes. Randomized clinical trials
hould be pursued to definitively address the issue of
ptimal timing; nevertheless, these observations argue that,
ending these trials, the decision on timing of CABG after
STEMI, including upstream planning, may be individu-
lized based on the judgment of experienced physicians and
urgeons in an effort to optimize both patient outcomes and
esource utilization.
eprint requests and correspondence: Dr. Jeffrey L. Anderson,
ardiovascular Department, Intermountain Medical Center, Univer-
ity of Utah School of Medicine, 5121 South Cottonwood Street,
urray, Utah 84107-5701. E-mail: jeffrey.anderson@imail.org.
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